Jeremy Grummet

Dr Jeremy Grummet is a urological surgeon with specific training and expertise in urological cancers. He performs MRI-targeted transperineal biopsy for maximal accuracy and minimal morbidity in prostate cancer diagnosis.

Dr Grummet also performs both robotic and open radical prostatectomy for the treatment of prostate cancer and is trained in brachytherapy (radioactive seed implantation). He routinely performs laparoscopic (keyhole) surgery for kidney cancer.

In addition to his expertise in uro-oncology, Dr Grummet also treats a wide range of general urological problems, performing surgery for kidney stones (using laser ablation), benign prostate disease, post-prostatectomy incontinence and erectile dysfunction and vasectomy.

Dr Grummet completed his formal training in urology obtaining his FRACS in 2007. 　The following year he completed a Clinical Uro-Oncology Fellowship under the supervision of Dr Martin Gleave at the Prostate Centre in Vancouver, Canada. During his Fellowship year Dr Grummet helped establish the robotic prostatectomy program at Vancouver General Hospital and completed a Robotic Surgery Mini-Residency at the University of California Irvine.

Dr Grummet has presented widely at multiple national and international conferences on the benefits of surgery for high risk localized prostate cancer, and is a strong advocate for active surveillance for low risk prostate cancer to minimise unnecessary treatment. 　He is an investigator on the PRIAS study, the largest worldwide study assessing outcomes　for patients on active surveillance.

Publications – Peer Reviewed

Risk factors for infection following prostate biopsy

Anderson E, Leahy O, Cheng AC, Grummet J.
BMC Infect Dis. 2015 Dec 23;15(1): 580.

Current practice of prostate biopsy in Australia and New Zealand: A survey.

Davis P, Paul E, Grummet J.
Urol Ann. 2015: Jul-Sep; 7(3): 315-9.

The state of TRUS biopsy sepsis in Australia: Re-admissions to Victorian Hospitals with TRUS biopsy-related infection over 5 years.

Roth H, Millar J, Cheng A, Byrne A, Evans S, Grummet J.
BJU Int. 2015: Oct;116 Suppl 3:49-53. doi: 10.1111/bju13209.

Could MRI solve the prostate cancer conundrum?

Grummet J, O'Sullivan R.
Med J Aust 2015 May 4; 202(8): 410-11.

A high PSA level in a man with suspected prostatitis. It's just due to inflammation, right?

Grummet J.
Medicine Today 2015; 16(5); 61-62.

Testicular loss following bacterial epididymo-orchitis: Case report and literature review.

Fehily SR, Trubiano JA, McLean C, Teoh BW, Grummet JP, Cheery CL, Vujovoc O.
Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E149-51.

Significant impact of transperineal template biopsy of the prostate at a single tertiary institution.

Huang S, Reeves F, Preece J, Satasivam P, Royce P, Grummet J.
Urology Annals 2015: Oct-Dec;7(4):428-32.

Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery.

Satasivam P, Reeves S, Rao K, Ivey Z, Basto M, Yip M, Roth H, Grummet J, Goad J, Moon D, Appu S, Lawrentschuk N, Bolton D, Kearsley J, Costello A, Frydenberg M.
BJU Int. 2015 Oct;116(4):590-5. doi: 10.1111/bju.13075.

Penthrox alone versus Penthrox plus PILA for analgesia in TRUS-guided prostate biopsy.

Huang S, Pepdjonovic L, Konstantatos A, Frydenberg M, Grummet J.
ANZ J Surg 2015 Feb 5. doi: 10.1111/ans.12974.

Transperineal biopsy prostate cancer detection in first biopsy and post-negative TRUS biopsy settings: The Victorian Transperineal Biopsy Collaboration experience.

Ong WL, Weerakoon M, Huang S, Paul E, Lawrentschuk N, Frydenberg M, Moon D, Murphy D, Grummet J.
BJU Int. 2015 Oct;116(4):568-76. doi: 10.1111/bju.13031.

Primary apocrine adenocarcinoma of scrotum suspected as urothelial carcinoma metastasis: a clinical and pathological dilemma.

Sean Huang, Mark Frydenberg, Alan Pham, Jeremy P. Grummet.
Urology Annals. 2015 Jan;7(1):97-9.

TRUS biopsy sepsis and the rise of carbapenem antibiotic use.

Leahy O, O'Reilly M, Phillips D, Dyer D, Grummet J.
ANZ J Surg 2014 Dec;85(12):931-5. doi: 10.1111/ans.12933.

Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?

Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, O'Reilly M, Murphy D.
BJU Int. 2014 Sep;114(3):384-8.

Is zero sepsis alone enough to justify transperineal prostate biopsy?

Murphy DG, Weerakoon M, Grummet J.
BJU Int. 2014 Jul;114(1):3-4.

Trans-perineal prostate biopsy: template-guided or free-hand?

Dundee PE, Grummet J, Murphy DG
BJU Int. 2014 May;115(5):681-3. doi: 10.1111/bju.12860.

A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.

Clark AK, Taubenberger AV, Taylor RA, Niranjan B, Chea ZY, Zotenko E, Sieh S, Pedersen JS, Norden S, Frydenberg M, Grummet JP, Pook DW; Australian Prostate Cancer BioResource, Stirzaker C, Clark SJ, Lawrence MG, Ellem SJ, Hutmacher DW, Risbridger GP.
Biomaterials. 2013 Jul;34(20):4777-85.

Splash! The spontaneous rupture of a bladder diverticulum: a rare cause of an acute abdomen.

Leahy O, Grummet J.
ANZ J Surg. 2013 Oct;83(10):792-3.

The 'green whistle': a novel method of analgesia for transrectal prostate biopsy.

Grummet J, Huang S, Konstantatos A, Frydenberg M.
BJU Int. 2012 Dec;110 Suppl 4:85-8.

Radical prostatectomy for high-risk clinically localized prostate cancer: a prospective single institution series.

Koupparis AJ, Grummet JP, Hurtado-Coll A, Bell RH, Buchan N, Goldenberg SL, Gleave ME.
Can Urol Assoc J. 2011 Dec;5(6):E156-61.

Paraneoplastic syndromes in prostate cancer.

Hong MK, Kong J, Namdarian B, Longano A, Grummet J, Hovens CM, Costello AJ, Corcoran NM.
Nat Rev Urol. 2010 Dec;7(12):681-92.

Vesicourethral anastomosis with 2-octyl cyanoacrylate adhesive in an in vivo canine model.

Grummet JP, Costello AJ, Swanson DA, Stephens LC, Cromeens DM.
Urology. 2002 Nov;60(5):935-8.

Laser welded vesicourethral anastomosis in an in vivo canine model: a pilot study.

Grummet JP, Costello AJ, Swanson DA, Stephens LC, Cromeens DM.
J Urol. 2002 Jul;168(1):281-4.